Zdrowie i gospodarka · 08/11/2023
FDA Announces Availability of Final Guidance for Real-Time Oncology Review
The FDA is releasing a final guidance for industry on Real-Time Oncology Review (RTOR), providing recommendations for submitting new drug and biologics applications with oncology indications for expedited review.